20th BayHelix Annual Conference

Event description:

Novotech is proud to be a Gold sponsor of the 20th BayHelix Annual Conference on January 6 at the Grand Hyatt SFO in San Francisco.  

Our Novotech experts will be available to discuss tailored solutions designed to accelerate the progress of your clinical trials. 

Discover the advantages of partnering with Novotech:

• Proven Track Record: With 26 years of experience, Novotech has experience with over 5,000 clinical projects.
• Fundraising: Equity Funding Model designed to “prime” the additional funding (less than $1M USD) you may need to bring your development program to clinic.   
• Global Reach: Benefit from our extensive network and global presence including a 700+ team in China supporting NMPA interactions.
• Drug Development Planning and/or FDA/EMA Interactions - Comprehensive "lab to launch" preclinical and clinical development services.

Don't miss this opportunity to connect with Novotech at the 20th BayHelix Annual Conference and explore how our expertise can elevate your clinical development plans in 2024 and beyond.